Time Program Presenters

8:30- 8:45 Opening	Prof. Nguyen Duc Hinh, President of Hanoi Medical University Prof. Shuichi Kaneko, Kanazawa University, Coordinator Dr Takeshi Kasai, WHO WPRO

Session 1 (Chairperson Prof. Nguyen Van Kinh)

8:50- 9:10	1-1. WHO's Vision on Viral Hepatitis Dr Takeshi Kasai, WHO WPRO
9:10- 9:30	1-2. Viral Hepatitis control in Vietnam Prof. Nguyen Van Kinh, National Hospital for Tropical Disease
9:30- 9:50	1-3. Epidemiology and Treatment of HBV infected patient in VietNam Dr Tran Ngoc Anh, Hanoi Medical University
9:50- 10:10	1-4. Tenofovir and lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus in highly viremic mothers in Vietnam Dr. Nguyen Van Bang, Hanoi Medical University
10:10- 10:30	1-5. Epidemiology and Treatment of HBV-infected Patients in Vietnam Dr. Nguyen Ngoc Phuc, Hanoi Medical University
10:30- 10:45	Coffee break

 

Session 2 (Chairperson Prof. Nguyen Van Thuc )

10:45- 11:05	2-1. HBV and HCV Epidemiology and Genotypes spread in Mongolia Prof. Tsendsuren Oyunsuren, National University of Mongolia
11:05- 11:25	2-2. Chronic Hepatitis B and Chronic Hepatitis C treatment in Mongolia Prof. Davaadorj Duger, Mongolian, National University of Medical Sciences
11:30- 13:30	Lunch

 

Session 3 (Chairperson Assoc. Prof. Ngo Van Toan and Prof. Tsendsuren Oyunsuren)

13:30- 13:50	3-1. Functional Roles of Hepatitis Virus X protein (HBx) Prof. Seishi Murakami, Kanazawa Gakuin University
13:50- 14:10	3-2. Molecular Biology of Cancer Metastasis Prof. Katsuji Yoshioka, Kanazawa University
14:10-14:30	3-3. HIV infection in Asia Dr Azumi Ishizaki, Kanazawa University
14:30- 14:50	3-4. HIV coinfection with hepatitis viruses in Asia Prof Hiroshi Ichimura, Kanazawa University
14:50- 15:10	Coffee Break

 

Session 4 (Chairperson Assoc. Prof. Nguyen Vu Trung and Prof. Seishi Murakami)

15:10-15:30	4-1. Strategy for Follow-up Check-ups for Hepatitis Patients in Ishikawa, Japan Dr Tetsuro Shimakami, Kanazawa University
15:30- 15:50	4-2. Treatment of HBV-infected patients in Japan Prof. Yasunari Nakamoto, Fukui University
15:50- 16:10	4-3. Reactivation of hepatitis B after immunosuppressive chemotherapy in Japan Dr Naoki Oishi, Kanazawa University
16:10- 16:30	4-4. Treatment of HCV-infected patients in Japan and an Experimental Model of HCV Infection Prof. Masao Honda, Kanazawa University
16:30- 17:00	Discussion
17:00	Closing Remarks Prof. Nguyen Duc Hinh, President of Hanoi Medical University